GlassScriptPhysician profile
Michael Geylikman
NPI 1770602328
$993.96
in general payments reported to CMS, 2019-2025
8 companies · $359 in 2025
The $359 reported for 2025 was more than what 86% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.31 · 2020: $133 · 2022: $159 · 2023: $216 · 2024: $66.22 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342 · Education: $275 · Gift: $23.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.27 |
| Education | $275.00 |
| Gift | $23.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $347.77 | 2022-2025 | |
| Align Technology, INC. | $288.58 | 2019-2025 | Invisalign |
| Dentsply Sirona INC | $115.95 | 2022-2024 | Waveone Gold Conform Fit, Midwest Tradition Pro, Q-Mix |
| Zimmer Biomet Holdings, INC. | $100.00 | 2020 | |
| Envista Holdings Corporation | $89.04 | 2025 | Spark |
| Orapharma, A Division of Bausch Health US, LLC | $22.74 | 2023 | Arestin |
| A-Dec, INC. | $15.00 | 2024 | |
| Philips North America LLC | $14.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Geylikman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.